Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-039376
Filing Date
2023-02-14
Accepted
2023-02-14 17:14:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d459284dsc13g.htm SC 13G 37594
  Complete submission text file 0001193125-23-039376.txt   39417
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filed by) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4
Business Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4 908-541-5456
Bausch & Lomb Corp (Subject) CIK: 0001860742 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93990 | Film No.: 23631558
SIC: 3851 Ophthalmic Goods